-
Groups call for action as cases and hospitalizations surge again.
-
Long COVID is the latest entry into a long list of potentially chronic, pandemic-associated infections. For many long COVID patients, some symptoms may be the result of a reactivation of an Epstein-Barr infection.
-
Disparate public health messaging from political officials, news media, and online outlets has occurred throughout the COVID-19 pandemic in the United States. Some have wanted to ascribe lower rates of compliance with public health guidance to political affiliation.
-
Researchers found many survivors of COVID-19 exhibited significant loss of health six months after their acute illness, with greater risk associated with severity of the acute infection.
-
Right after the FDA issued an emergency use authorization for one drug, feds pressed pause on distributing another.
-
The WHO Solidarity Trial Consortium found remdesivir, hydroxychloroquine, lopinavir, and interferon regimens produced “little or no effect” on relevant outcomes.
-
Plaintiffs expected to challenge ruling in ongoing saga over Houston facility’s policy.
-
Since the first cases of COVID-19 were reported in the United States, severe ischemic strokes also have been reported in some of these patients, some with large vessel occlusions and case reports of thrombectomy for treatment.
-
Researchers found extending the upper limit of HPV vaccination to age 30 to 45 years is not cost-effective.
-
The Pfizer/BioNTech solution will be available for Americans age 12 to 15 years.
